Organisation paid for research Program year 2024 Source: CMS Open Payments

Bayou City Research

Neither a doctor nor a teaching hospital

Research payments

$1,491,560

22 payments

Through program year 2024, Bayou City Research is reported as receiving $1,491,560 in research payments, across 22 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$7,945	4
2020	Research	$175,381	1
2019	Research	$1,308,234	17

Breakdown

Who paid Research payments · program years 2019–2024

Adlon Therapeutics L.P. $1,224,573 13 payments
Purdue Pharma L.P. $259,042 5 payments
Supernus Pharmaceuticals, Inc. $7,945 4 payments

Studies the money was for Research payments · program years 2019–2024

063-020 $1,483,615 18 payments
A Phase IV, Open-Label, Flexible-Dose Safety Trial Evaluating Spn-812 Administered With Psychostimulants in Children and Adolescents (6 to 17 Years of Age) With Disorder (Adhd) Attention-Deficit/Hyperactivity $7,945 4 payments

What the money was spent on Research payments · program years 2019–2024

Patient care $7,945 4 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.